0001493152-24-046621.txt : 20241118 0001493152-24-046621.hdr.sgml : 20241118 20241118194025 ACCESSION NUMBER: 0001493152-24-046621 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241108 FILED AS OF DATE: 20241118 DATE AS OF CHANGE: 20241118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lalonde James Joseph CENTRAL INDEX KEY: 0002030844 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42204 FILM NUMBER: 241473012 MAIL ADDRESS: STREET 1: 1895 LEXINGTON AVENUE CITY: SAN MATEO STATE: CA ZIP: 94402 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invizyne Technologies Inc CENTRAL INDEX KEY: 0002010788 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834550057 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 ROYAL OAKS DR CITY: MONROVIA STATE: CA ZIP: 91016 BUSINESS PHONE: (626) - 415 - 1488 MAIL ADDRESS: STREET 1: 750 ROYAL OAKS DR CITY: MONROVIA STATE: CA ZIP: 91016 3 1 ownership.xml X0206 3 2024-11-08 0 0002010788 Invizyne Technologies Inc IZTC 0002030844 Lalonde James Joseph C/O 750 ROYAL OAKS DRIVE, SUITE 106 MONROVIA, CA 91016 1 0 0 0 Stock Options for Common Stock 2.44 2021-02-01 2028-01-31 Common Stock 7791 D Stock Options for Common Stock 8.00 2024-07-01 2031-03-31 Common Stock 51939 D The options vest as follows: The first 130 shares vest per month starting February 1, 2021, and the balance vest at monthly basis thereafter, and become exercisable once vested. All shares are vested by 01/31/2026. The options vest as follows: The first 2,597 shares vest on July 1, 2024, and the balance vest at the rate of 2,597 shares per quarter, commencing on October 1, 2024, and become exercisable once vested. All shares are vested by 03/31/2029. /s/ James J. Lalonde 2024-11-08